Table 1.
FBF, ml/min |
FVC, ml·min−1·mmHg−1 ×10−3 | |||
---|---|---|---|---|
At rest | Contraction | At rest | Contraction | |
DETC | ||||
Before | 1.8±0.4 | 3.2±0.6* | 17.7±0.4 | 26.9±4.9* |
After | 1.8±0.4 | 3.2±0.7* | 17.2±4.0 | 24.0±5.3* |
Tempol | ||||
Before | 1.5±0.3 | 2.8±0.8* | 16.1±4.0 | 24.5±7.6* |
After | 1.6±0.4 | 2.9±0.6* | 17.9±5.5 | 28.4±7.8*† |
DMTU | ||||
Before | 1.6±0.3 | 3.1±0.4* | 15.7±3.7 | 26.0±4.4* |
After | 1.6±0.4 | 3.1±0.4* | 15.3±4.2 | 27.0±4.1* |
Apocynin | ||||
Before | 1.7±0.4 | 3.0±0.6* | 16.3±3.2 | 24.8±4.8* |
After | 1.7±0.4 | 3.0±0.7* | 16.2±2.8 | 26.1±5.1* |
Values are means ± SE; n = 4 rats in each group. FBF, femoral blood flow; FVC, femoral vessel conductance; DETC, diethyldithiocarbamate; tempol, 4-hydroxy-2,2,6,6-tetramethyl piperidine 1-oxyl; DMTU, dimethylthiourea.
P < 0.05 vs. at rest;
P < 0.05 vs. after.